本文選題：剖宮產(chǎn)　切入點(diǎn)：術(shù)后鎮(zhèn)痛　出處：《中國婦幼保健》2016年24期 　論文類型：期刊論文

【摘要】：目的探討鹽酸納布啡注射液(瑞靜)用于剖宮產(chǎn)術(shù)后鎮(zhèn)痛臨床效果。方法將126例行剖宮產(chǎn)進(jìn)行分娩產(chǎn)婦隨機(jī)分為研究組和對照組各63例,同期采集就診于本醫(yī)院體檢中心體檢結(jié)果為正常的健康未孕女性為健康組,且基線數(shù)據(jù)與入組產(chǎn)婦基本相符。研究組采用納布啡注射液作為產(chǎn)后自控鎮(zhèn)痛維持藥物,對照組單純采用以舒芬太尼及氟比洛芬酯為主的自控鎮(zhèn)痛法。分別于分娩后24、48 h以及72 h使用疼痛視覺模擬評分(VAS評分)和Ramsay鎮(zhèn)靜評分對產(chǎn)婦產(chǎn)后鎮(zhèn)痛效果進(jìn)行評價(jià),同時(shí)監(jiān)測兩組產(chǎn)婦產(chǎn)后心率血壓等指標(biāo);檢測兩組產(chǎn)婦及健康組血清IL-17表達(dá)水平。通過液相質(zhì)譜及紫外分光技術(shù)檢測兩組產(chǎn)婦乳汁中納布啡及其他鎮(zhèn)痛藥物代謝產(chǎn)物。結(jié)果與對照組相比,研究組產(chǎn)婦術(shù)后VAS評分及Ramsay鎮(zhèn)靜評分未見明顯差異(P0.05);研究組產(chǎn)后24、48 h及72 h血清IL-17水平明顯低于對照組,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。產(chǎn)婦乳汁中納布啡水平(12.25±2.48)明顯低于其他鎮(zhèn)痛藥物的含量,差異有統(tǒng)計(jì)學(xué)意義(P0.05)。結(jié)論納布啡用于剖宮產(chǎn)術(shù)后鎮(zhèn)痛藥物具有良好的鎮(zhèn)痛效果,并可明顯減低血清致痛因子IL-17水平,且乳汁中藥物含量低,對于改善產(chǎn)婦剖宮產(chǎn)術(shù)后疼痛以及新生兒喂養(yǎng)具有重要的臨床意義。
[Abstract]:Objective to investigate the clinical effect of naporphine hydrochloride injection (Ruijing) on postoperative analgesia of cesarean section. Methods 126 cases of cesarean section were randomly divided into study group and control group (63 cases each). At the same time, the results of the physical examination in our hospital's physical examination center showed that the normal healthy non-pregnant women were the healthy group, and the baseline data were basically consistent with those of the pregnant women. The study group used naporphine injection as the maintenance drug for postpartum patient-controlled analgesia. In the control group, sufentanil and flurbiprofen ester were used as the main analgesic method. The analgesic effect of puerpera was evaluated by visual analogue pain score (VAS) and Ramsay sedative score at 24 hours after delivery and 72 hours after delivery. The postpartum heart rate and blood pressure of the two groups were monitored at the same time. The levels of serum IL-17 were detected in two groups of puerpera and healthy women, and the metabolites of naporphine and other analgesic drugs in the milk of the two groups were detected by liquid phase mass spectrometry and ultraviolet spectrophotometry. The results were compared with those of the control group. There was no significant difference in VAS score and Ramsay sedation score between the study group and the control group, and the serum IL-17 level in the study group was significantly lower than that in the control group at 24 h and 72 h postpartum. The difference was statistically significant (P 0.05). The level of naporphine in milk of puerpera was significantly lower than that of other analgesic drugs (12.25 鹵2.48), and the difference was statistically significant (P 0.05). Conclusion naborphine has a good analgesic effect for postoperative analgesia of cesarean section. It can obviously reduce the IL-17 level of serum pain-causing factor, and the drug content in milk is low, which has important clinical significance for improving the pain after cesarean section and newborn feeding.
【作者單位】： 曲靖市第一人民醫(yī)院麻醉科;
【分類號(hào)】：R614

【相似文獻(xiàn)】

相關(guān)期刊論文 前4條

1 何毓嘉，遲傳金，杜宇紅，，周信和;納布啡的合成[J];中國醫(yī)藥工業(yè)雜志;1994年07期

2 李鳳俠;;對疼痛反應(yīng)的性別差異[J];國外醫(yī)學(xué)情報(bào);1999年10期

3 徐建國;李德馨;;納布啡(nalbuphine)的藥理和臨床應(yīng)用[J];國外醫(yī)學(xué).麻醉學(xué)與復(fù)蘇分冊;1990年06期

4 ;[J];;年期

相關(guān)重要報(bào)紙文章 前10條

1 本報(bào)記者 張琪;納布科名存實(shí)亡[N];中國能源報(bào);2013年

2 佟剛;納布科天然氣管線盼來“綠燈”[N];中國石化報(bào);2009年

3 本報(bào)記者 王曉蘇;土耳其與歐盟四國簽署納布科協(xié)議[N];中國能源報(bào);2009年

4 本報(bào)評論員 周飆;納布科的紛爭與得失[N];21世紀(jì)經(jīng)濟(jì)報(bào)道;2009年

5 本報(bào)記者 于歡;納布科：一場靜悄悄的能源戰(zhàn)爭[N];中國能源報(bào);2009年

6 焦旭;地中海國家押注“納布科西線”[N];中國能源報(bào);2013年

7 本報(bào)駐莫斯科記者 韓顯陽;“南溪”與“納布科”之爭的背后[N];光明日報(bào);2009年

8 上海歐洲學(xué)會(huì)副秘書長 張祖謙;納布科輸氣管計(jì)劃“四兩撥千斤”[N];上海證券報(bào);2009年

9 CNE記者 宋飛;納布科天然氣管道項(xiàng)目前景令人堪憂[N];中國電力報(bào);2011年

10 丹尼爾·格雷爾伯 編譯 李慧;納布科項(xiàng)目重在市場而非政治[N];中國能源報(bào);2012年

相關(guān)碩士學(xué)位論文 前1條

1 盧森;納布啡在腹式子宮切除術(shù)后靜脈自控鎮(zhèn)痛（PCIA）中的應(yīng)用[D];吉林大學(xué);2016年

本文編號(hào)：1650028